Balaxi Pharmaceuticals
BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth
1d
0.0%
1w
4.8%
1m
18.3%
3m
25.4%
6m
32.7%
1y
56.0%
5y
23.1%
10y
27.8%
all
29.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 35 0%
34
47.8
Company Overview

Sales
276 Cr
Growth: 8.8%
Profit after Tax
14.5 Cr
Growth: -23.2%
Micro Cap
193 Cr
P/E: 13.3x
Industry P/E: 29.2x
Fundamentals

Sales (Cr) ₹ 276
Growth 8.8%
EBITDA 7.9%
P/S 0.7x
Dividend 0.0%
P/E 13.3x
Book Value ₹ 31.7
PEG Ratio 1.5x
ROE 8.4%
P/B 1.1x
Shareholding Pattern

Institutions
Elara India Opportunities Fund Limited
9.5 %
Marshal Global Capital Fund Ltd
9.5 %
Amol Anand Mantri
1.73 %
Iepf
0.75 %
Promoters
Balaxi Overseas Private Limited
70.0 %
Ashish Maheshwari
1.81 %
Minoshi Maheshwari
1.06 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
Investors (18)
Followers (1)